🇺🇸 ATG in United States
1,175 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 21 April 2025 – 21 April 2026
- Total reports: 1,175
Most-reported reactions
- Off Label Use — 170 reports (14.47%)
- Cytomegalovirus Infection — 164 reports (13.96%)
- Pyrexia — 149 reports (12.68%)
- Product Use In Unapproved Indication — 146 reports (12.43%)
- Drug Ineffective — 132 reports (11.23%)
- Acute Graft Versus Host Disease — 88 reports (7.49%)
- Sepsis — 88 reports (7.49%)
- Graft Versus Host Disease — 85 reports (7.23%)
- Chronic Graft Versus Host Disease — 78 reports (6.64%)
- Adenovirus Infection — 75 reports (6.38%)
Other Immunology approved in United States
Frequently asked questions
Is ATG approved in United States?
ATG does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for ATG in United States?
ITB-Med LLC is the originator. The local marketing authorisation holder may differ — check the official source linked above.